CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges
Matthew J Rendo,1 Jacinth J Joseph,2 Liem Minh Phan,3 Christin B DeStefano4 1Department of Hematology/Oncology, Brooke Army Medical Center, San Antonio, TX, USA; 2Blood and Marrow Transplant Center, Methodist Le Bonheur Healthcare, Memphis, TN, USA; 3Clinical Investigation Facility, David Grant USAF...
Main Authors: | Rendo MJ, Joseph JJ, Phan LM, DeStefano CB |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-08-01
|
Series: | Blood and Lymphatic Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/car-t-cell-therapy-for-patients-with-multiple-myeloma-current-evidence-peer-reviewed-fulltext-article-BLCTT |
Similar Items
-
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
by: Gils Roex, et al.
Published: (2020-12-01) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients
by: Angelo Maiolino, et al.
Published: (2021-11-01) -
Chimeric antigen receptor T cell therapy for multiple myeloma
by: Kana Hasegawa, et al.
Published: (2019-06-01) -
CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil
by: Vania Hungria, et al.
Published: (2023-04-01) -
The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma
by: Meera Mohan, et al.
Published: (2021-09-01)